4d Molecular Therapeutics, Inc. (FDMT)

Last Year

14-May-23 -- 13-May-24

Time Period:

($11.23M) Net Amount

Buy:	0	--
Sell:	($11.23M)	$17.27 - $19.53

Company Sentiment

Other

Other

Insider Trading Sentiment: Sell

Sentiment Breakdown by Insider

0

(3)

2

(2)

1

(1)

5

0

1

+1

0

+2

0

+3

Two Year Chart

14-May-22 -- 13-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
05-Jan-24 5:44 PM View:	04-Jan-24 Market Sale ($10.55M)	Viking Global Investors Lp 10% Owner		4d Molecular Therapeutics, Inc. - FDMT	(11%) 4.79M to 4.25M	0	($10.55M) (11%)	--	$19.53	Show Txns Hide Txns

16-May-23 8:52 PM View:	15-May-23 Option Exercise $28.23K	Moretti August J Chief Financial Officer		4d Molecular Therapeutics, Inc. - FDMT	37% 8.04K to 11.04K	0	0	--	--	Show Txns Hide Txns

12-Feb-24 8:22 PM View:	08-Feb-24 Private Sale (Planned) ($2.50M)	Kirn David Chief Executive Officer Director		4d Molecular Therapeutics, Inc. - FDMT	(16%) 1.26M to 1.06M	0	($684.53K) (3%)	--	$17.27 - $18.41	Show Txns Hide Txns

07-Feb-24 8:32 PM View:	05-Feb-24 Sale (Planned) ($16.59K)	Kim Robert Young Chief Medical Officer		4d Molecular Therapeutics, Inc. - FDMT	(35%) 1.59K to 1.04K	0	0	--	--	Show Txns Hide Txns

18-Apr-24 8:48 PM View:	16-Apr-24 Planned Option Sale ($45.04K)	Bizily Scott Chief Legal Officer		4d Molecular Therapeutics, Inc. - FDMT	0% 1.74K	0	0	--	--	Show Txns Hide Txns